CMS 2027 Outpatient Pay Proposal: 2.4% Increase, 340B Cuts and Site-Neutral Expansion

Bypaulgruensfelder
Chief Healthcare Executive July 6, 2026
Read Full Article →
AI-Generated Summary

CMS is proposing a 2.4% increase in outpatient and ambulatory surgical center payments for 2027, alongside a cut to the 340B drug discount and a broader push toward site-neutral payment. The proposed OPPS rule raises rates 3.2% for cost inflation, offset by a 0.8% productivity adjustment, and adds $55 million for hospitals in Alaska and Hawaii. CMS would reduce the 340B discount to 33.4% of average sales price, down from roughly 40%, citing wide disparities in hospital acquisition costs. The agency also proposes lower hospital reimbursement for some imaging services under site-neutral policy and is seeking comment on stronger price transparency requirements. Hospital groups, including America’s Essential Hospitals, have criticized the proposal as a blow to safety-net funding.

Why It Matters

Payment rules set the revenue baseline for every outpatient and ASC operator. A 2.4% update trailing real cost growth, 340B compression, and expanding site-neutral policy all tighten hospital outpatient economics — and shift relative advantage toward freestanding ASCs and physician-owned sites that many growth-stage platforms operate.

2027 OPPS rule ASC reimbursement 340B discount site-neutral payments CMS proposed rule price transparency

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

How much is CMS proposing to increase outpatient and ASC payments for 2027?

CMS proposes a 2.4% payment increase for both hospital outpatient departments and ambulatory surgical centers in calendar year 2027. The update reflects a 3.2% increase for higher costs of goods and services, offset by a 0.8% productivity adjustment, plus roughly $55 million in added payments for hospitals in Alaska and Hawaii.

What happens to the 340B drug discount under the proposed 2027 OPPS rule?

CMS proposes reducing the 340B discount to 33.4% of a drug’s average sales price, down from the current discount of about 40%. The agency cites a hospital survey showing significant disparities between hospital acquisition costs and current discount levels.

Does the 2027 OPPS proposal expand site-neutral payment?

Yes. CMS proposes reducing hospital reimbursement for certain imaging services and continues pushing to pay hospitals and clinics at similar rates for some outpatient services. Hospital groups have opposed the change, while CMS frames it as giving patients lower-cost options for care.

Similar Posts

  • Patients Choose the Hospital Brand First: 53% Pick a System Before a Doctor

    Bypaulgruensfelder

    When patients face a new health issue, a majority now choose the hospital or system first: 53% select a hospital first or pick a hospital and physician simultaneously, according to a July 2026 U.S. News & World Report survey of 500 U.S. adults who arranged care in the past 24 months. Hospital brand loyalty runs deep enough that 20% would switch providers to receive care at their preferred hospital. U.S. News attributes the pull to perceived safety, technology, and coordinated care across a trusted system. The data lands as U.S. News prepares its 37th Best Hospitals rankings (Aug. 4, 2026), adding new state and metro specialty rankings.

  • Healthcare M&A Trends Q2 2026: PPM, Outpatient, and PE Scrutiny

    Bypaulgruensfelder

    Healthcare M&A stayed steady in Q2 2026, driven by consolidation, AI integration, and cross-sector deals despite intensifying scrutiny of PE-backed MSO arrangements. Physician practice management remained active, with enablement platforms like Privia Health offering an alternative to full-ownership roll-ups. Ascension closed its AMSURG acquisition to become the third-largest ambulatory surgery center platform. For-profit systems kept divesting non-core assets—CHS sold Crestwood Medical Center for $459 million and four Arkansas hospitals to Freeman Health, part of a $1.2 billion, nine-hospital divestiture plan. Home health, hospice, and behavioral health saw continued PE-backed roll-ups, while digital health and health IT capital concentrated around scaled, high-performing platforms amid tariff-driven volatility and antitrust pressure.

  • Commure Targets the 35–50% of Referrals That Never Convert

    Bypaulgruensfelder

    Between 35% and 50% of medical referrals never result in a completed specialist appointment, and those that do take 31 days on average — a gap Commure’s new Orchestrator platform aims to close by automating end-to-end referral management and patient intake. The AI platform replaces fax-based referral workflows, targets referral leakage, and cuts pre-visit administrative work such as authorization holds and manual hand-offs. Commure frames the economics plainly: every unconverted referral is both a patient lost to follow-up and revenue that never shows up on the books. The launch adds to a fast-growing category of AI tools aimed at the pre-visit workflow, where leakage and intake friction remain among the most measurable revenue drains for multi-site provider groups.

  • Select Medical Goes Private in $3.9B Welsh Carson-Led Deal

    Bypaulgruensfelder

    Select Medical Holdings completed a $3.9 billion take-private on July 1, 2026, led by its founders and private equity firm Welsh, Carson, Anderson & Stowe at $16.50 per share — an 18% premium to its pre-announcement close. The Mechanicsburg, Pa. operator runs outpatient physical therapy (including NovaCare) across roughly 1,850 locations in 36 states, plus 104 long-term acute-care hospitals and 38 rehabilitation hospitals, with more than 45,000 employees and $5.5 billion in 2025 revenue. Management rolled equity alongside the sponsor, keeping operating leadership invested through the next value-creation cycle in post-acute and outpatient rehab.

  • Allina Health to Pay $12.5M to Settle Website Pixel Litigation

    Bypaulgruensfelder

    Allina Health System agreed to pay $12.5 million to resolve a consolidated class action over its use of website tracking pixels, one of the larger settlements in the ongoing healthcare pixel litigation wave. Plaintiffs alleged the tools disclosed personally identifiable information and protected health information to third parties including Meta and Google, in violation of the Electronic Communications Privacy Act, the Minnesota Health Records Act, and state deceptive trade practices law. Allina denies wrongdoing. The fund splits into $10.3 million for patient portal, bill-pay, and scheduling users and $2.2 million for other patients, covering activity from September 2018 through May 2026.

  • Federal Court Strikes Down South Dakota Dental Advertising Restrictions

    Bypaulgruensfelder

    A federal court struck down South Dakota’s dental advertising restrictions, ruling that dentists may market bona fide credentials—including implant dentistry—even in areas the American Dental Association does not formally recognize as specialties. On July 20, 2026, U.S. District Judge Karen Schreier granted summary judgment to the American Academy of Implant Dentistry and Sioux Falls dentist Dr. Edward Kusek, and denied the South Dakota Board of Dentistry and Attorney General Marty Jackley. The plaintiffs argued the Board’s 2023 rules violated First Amendment commercial-speech protections. The decision tracks earlier AAID victories against the Texas, California, and Florida boards, reinforcing that truthful, non-misleading specialty advertising by dentists is constitutionally protected.